BRPI0913822A2 - forma farmacêutica oral e uso da forma farmacêutica - Google Patents
forma farmacêutica oral e uso da forma farmacêuticaInfo
- Publication number
- BRPI0913822A2 BRPI0913822A2 BRPI0913822A BRPI0913822A BRPI0913822A2 BR PI0913822 A2 BRPI0913822 A2 BR PI0913822A2 BR PI0913822 A BRPI0913822 A BR PI0913822A BR PI0913822 A BRPI0913822 A BR PI0913822A BR PI0913822 A2 BRPI0913822 A2 BR PI0913822A2
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- oral
- oral dosage
- dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0856660A FR2936709B1 (fr) | 2008-10-02 | 2008-10-02 | Comprimes alcoolo-resistants. |
| PCT/EP2009/062836 WO2010037854A2 (fr) | 2008-10-02 | 2009-10-02 | Comprimés alcoolo-résistants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0913822A2 true BRPI0913822A2 (pt) | 2015-10-20 |
| BRPI0913822B1 BRPI0913822B1 (pt) | 2018-12-26 |
Family
ID=40547402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0913822A BRPI0913822B1 (pt) | 2008-10-02 | 2009-10-02 | forma farmacêutica oral de liberação controlada para evitar liberação imediata na presença de álcool, e uso da forma farmacêutica |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9492397B2 (pt) |
| EP (1) | EP2349227B1 (pt) |
| JP (1) | JP2012504582A (pt) |
| KR (1) | KR101632368B1 (pt) |
| CN (1) | CN102215827B (pt) |
| AU (1) | AU2009299810B2 (pt) |
| BR (1) | BRPI0913822B1 (pt) |
| CA (1) | CA2739018C (pt) |
| ES (1) | ES2683096T3 (pt) |
| FR (1) | FR2936709B1 (pt) |
| IL (1) | IL212008A (pt) |
| MX (1) | MX352326B (pt) |
| WO (1) | WO2010037854A2 (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| CN102639118B (zh) | 2009-07-22 | 2015-07-29 | 格吕伦塔尔有限公司 | 氧化稳定的抗干扰剂型 |
| FR2959935B1 (fr) * | 2010-05-14 | 2013-02-08 | Ethypharm Sa | Forme pharmaceutique orale alcoolo-resistante |
| US9877925B2 (en) | 2010-05-14 | 2018-01-30 | Ethypharm | Alcohol-resistant oral pharmaceutical form |
| BR112013005194A2 (pt) | 2010-09-02 | 2016-05-03 | Gruenenthal Gmbh | forma de dosagem resistente à violação compreendendo sal inorgânico |
| BR112014001091A2 (pt) | 2011-07-29 | 2017-02-14 | Gruenenthal Gmbh | comprimido resistente à adulteração que fornece liberação imediata do fármaco |
| EA201400172A1 (ru) | 2011-07-29 | 2014-06-30 | Грюненталь Гмбх | Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства |
| EP2838512B1 (en) | 2012-04-18 | 2018-08-22 | Grünenthal GmbH | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
| BR112016000194A8 (pt) | 2013-07-12 | 2019-12-31 | Gruenenthal Gmbh | forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila |
| EP3073994A1 (en) | 2013-11-26 | 2016-10-05 | Grünenthal GmbH | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
| JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
| US20190282500A1 (en) * | 2016-09-09 | 2019-09-19 | Cutispharma, Inc. | Suspensions and diluents for metronidazole and baclofen |
| ES2963929T3 (es) | 2017-05-29 | 2024-04-03 | Gruenenthal Gmbh | Forma farmacéutica oral multipartículas que proporciona liberación prolongada de tapentadol |
| GR1009751B (el) | 2019-03-22 | 2020-05-29 | "Φαρματεν Α.Β.Ε.Ε." | Σκευασμα παρατεταμενης αποδεσμευσης που περιλαμβανει οξαλικη ταπενταδολη και μεθοδος παρασκευης αυτου |
| EP4125847A4 (en) | 2020-04-03 | 2024-06-19 | Lpoxy Therapeutics, Inc. | ENTERAL AEROBIZATION THERAPY |
| US20230227671A1 (en) | 2020-05-22 | 2023-07-20 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing with food contact compliant agents |
| US20230182381A1 (en) * | 2020-07-10 | 2023-06-15 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing with food contact compliant agents |
| JP2024536134A (ja) | 2021-09-29 | 2024-10-04 | ループオキシー・セラピューティクス・インコーポレイテッド | 腸内好気性化治療 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6143037A (en) * | 1996-06-12 | 2000-11-07 | The Regents Of The University Of Michigan | Compositions and methods for coating medical devices |
| WO2002065834A2 (en) * | 2000-10-24 | 2002-08-29 | Smithkline Beecham Corporation | Novel formulations of carvedilol |
| US6902637B2 (en) * | 2001-01-23 | 2005-06-07 | Trw Inc. | Process for preparing free-flowing particulate phase stabilized ammonium nitrate |
| CA2447693A1 (en) * | 2001-05-31 | 2002-12-05 | Cima Labs Inc. | Taste-masking of highly water-soluble drugs |
| FR2842736B1 (fr) * | 2002-07-26 | 2005-07-22 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s) |
| NZ589750A (en) * | 2004-10-21 | 2012-07-27 | Aptalis Pharmatech Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| FR2881652B1 (fr) * | 2005-02-08 | 2007-05-25 | Flamel Technologies Sa | Forme pharmaceutique orale microparticulaire anti-mesuage |
| EP1898890A1 (en) * | 2005-06-16 | 2008-03-19 | Forest Laboratories, Inc. | Modified and immediate release memantine bead formulation |
| US20070092568A1 (en) * | 2005-10-10 | 2007-04-26 | Gore Subhash P | Galantamine compositions |
| KR20140088230A (ko) * | 2006-01-27 | 2014-07-09 | 앱탈리스 파마테크, 인코포레이티드 | 약 염기성 약물과 유기산을 포함하는 약물 전달 시스템 |
| DE102006006785B4 (de) * | 2006-02-14 | 2008-07-03 | BSH Bosch und Siemens Hausgeräte GmbH | Heizsystem mit Rückführung |
| FR2897267A1 (fr) * | 2006-02-16 | 2007-08-17 | Flamel Technologies Sa | Formes pharmaceutiques multimicroparticulaires pour administration per os |
| US20070202172A1 (en) * | 2006-02-24 | 2007-08-30 | Tomer Gold | Metoprolol succinate E.R. tablets and methods for their preparation |
| CA2645940A1 (en) * | 2006-03-21 | 2007-09-27 | Teva Pharmaceutical Industries Ltd. | Controlled release formulation of tolterodine |
| SI2719378T1 (sl) | 2006-06-19 | 2016-11-30 | Alpharma Pharmaceuticals Llc | Farmacevtski sestavki |
| US20080003286A1 (en) * | 2006-06-29 | 2008-01-03 | Sathya Narayana Vemula | Sustained delivery alfuzosin compositions |
-
2008
- 2008-10-02 FR FR0856660A patent/FR2936709B1/fr active Active
-
2009
- 2009-10-02 US US13/122,261 patent/US9492397B2/en active Active
- 2009-10-02 CA CA2739018A patent/CA2739018C/fr active Active
- 2009-10-02 BR BRPI0913822A patent/BRPI0913822B1/pt active IP Right Grant
- 2009-10-02 EP EP09783697.7A patent/EP2349227B1/fr active Active
- 2009-10-02 WO PCT/EP2009/062836 patent/WO2010037854A2/fr not_active Ceased
- 2009-10-02 KR KR1020117010114A patent/KR101632368B1/ko active Active
- 2009-10-02 MX MX2011003562A patent/MX352326B/es active IP Right Grant
- 2009-10-02 ES ES09783697.7T patent/ES2683096T3/es active Active
- 2009-10-02 JP JP2011529569A patent/JP2012504582A/ja active Pending
- 2009-10-02 AU AU2009299810A patent/AU2009299810B2/en active Active
- 2009-10-02 CN CN200980139219.7A patent/CN102215827B/zh active Active
-
2011
- 2011-03-29 IL IL212008A patent/IL212008A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP2349227B1 (fr) | 2018-05-30 |
| ES2683096T3 (es) | 2018-09-25 |
| MX352326B (es) | 2017-11-17 |
| WO2010037854A2 (fr) | 2010-04-08 |
| FR2936709A1 (fr) | 2010-04-09 |
| CA2739018C (fr) | 2017-02-28 |
| US9492397B2 (en) | 2016-11-15 |
| EP2349227A2 (fr) | 2011-08-03 |
| CA2739018A1 (fr) | 2010-04-08 |
| CN102215827B (zh) | 2016-10-05 |
| WO2010037854A3 (fr) | 2010-12-23 |
| US20110177138A1 (en) | 2011-07-21 |
| KR101632368B1 (ko) | 2016-06-21 |
| BRPI0913822B1 (pt) | 2018-12-26 |
| IL212008A0 (en) | 2011-06-30 |
| JP2012504582A (ja) | 2012-02-23 |
| AU2009299810A1 (en) | 2010-04-08 |
| FR2936709B1 (fr) | 2012-05-11 |
| IL212008A (en) | 2016-06-30 |
| CN102215827A (zh) | 2011-10-12 |
| AU2009299810B2 (en) | 2014-08-14 |
| KR20110070889A (ko) | 2011-06-24 |
| MX2011003562A (es) | 2011-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0913822A2 (pt) | forma farmacêutica oral e uso da forma farmacêutica | |
| SMT201600258B (it) | Composto indolico e suo uso farmaceutico | |
| BR112012013148A2 (pt) | formulação farmacêutica e uso | |
| BRPI0920216A2 (pt) | forma de dosagem intraoral em múltiplas porções e uso das mesmas | |
| DK2077729T3 (da) | Orale probiotiske doseringsformer | |
| ATE488227T1 (de) | Feste zubereitung mit alogliptin und pioglitazon | |
| HRP20180718T1 (hr) | Oligopeptidni spojevi i njihova upotreba | |
| SMT201500206B (it) | Composti spiro-ossindolici e loro uso come agenti terapeutici | |
| DK2346495T4 (da) | Farmaceutisk formulering 514 | |
| BRPI0917315A2 (pt) | anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica | |
| SMT201500218B (it) | Composti aril-fenil-solfonammido-cicloalchile e loro uso | |
| EP2240022A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| BRPI0816350A2 (pt) | Composições orais, produtos e métodos de uso | |
| EP2373681A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| BRPI1007494A2 (pt) | composto e uso do mesmo | |
| EP2474522A4 (en) | AGOME ELITE AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| BR112013014924A2 (pt) | kit de higiene oral e distribuidor para uso com o mesmo | |
| EP2236149A4 (en) | MEDICAL COMPOSITION | |
| ATE547093T1 (de) | Schäumbare mundpflegezusammensetzung | |
| EP2197448A4 (en) | dosing schedule | |
| BRPI0813587A2 (pt) | Composto, uso do mesmo, e, composição farmacêutica | |
| SMT201500273B (it) | Diidroetorfine e loro preparazione | |
| EP2341047A4 (en) | CYCLOHEXANE DERIVATIVE AND ITS PHARMACEUTICAL USE | |
| DK2131818T3 (da) | Ny doseringsform | |
| BRPI0812964A2 (pt) | Forma de dosagem farmacêutica oral sólida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/10/2009, OBSERVADAS AS CONDICOES LEGAIS. |